Abstract
Matrix metalloproteinases (MMPs) are a family of zinc-dependent neutral endopeptidases, collectively capable of degrading essentially all matrix components. Elevated levels of distinct MMPs are detected in tumor tissue or serum of patients with advanced cancer, and they are the major prognostic indicators in cancer. Inhibition of MMPs has been explored as a therapeutic goal for almost two decades. Nitric oxide (NO), a free radical plays an important role in signaling pathways in regulation of MMP expression. In the present study, we demonstrated the role of exogenous NO levels in the regulation of MMP2 and MMP9 (gelatinases A and B) in colon cancer cell line WiDr and its inhibition with emodin (a naturally occurring anthraquinone).
Similar content being viewed by others
Abbreviations
- MMP:
-
Matrix metalloproteinases
- NO:
-
Nitric oxide
- ECM:
-
Extracellular matrix
- NOs:
-
Nitric oxide synthases
- DMEM:
-
Dulbecco’s modified eagle medium
- PBS:
-
Phosphate-buffered saline
- EDTA:
-
Ethylenediaminetetra acetate
- SNP:
-
Sodium nitroprusside
- MTT:
-
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
- DMSO:
-
Dimethyl sulfoxide
- ELISA:
-
Enzyme-linked immunosorbent assay
- RT-PCR:
-
Reverse transcriptase-PCR
- MoMLV:
-
Molony murine leukemia virus
- TAE:
-
Tris acetate-EDTA buffer
- MMPI:
-
Matrix metalloproteinases inhibitors
References
Wittekind, C., & Neid, M. (2005). Oncology, 69(1), 14–16.
Ann, F. C., & Lynn, M. M. (1997). Journal of the National Cancer Institute, 89(17), 1260–1270.
Sang-Oh, Y., Soo-Jin, P., Chang-Hyun, Y., & An-Sik, C. (2003). Journal of Biochemistry and Molecular Biology, 36(1), 128–137.
Weiming, X., Li, Z. L., Marilena, L., Mohamed, A., & Ian, G. C. (2002). Cell Research, 12(5–6), 311–320.
Dai, F., Satoshi, K., & Rakesh, K. J. (2006). Nature Reviews Cancer, 6(7), 521–534.
Yoshihito, S., Nobuyo, S., & Shujiro, S. (2002). Z Naturforsch, 57c, 923–929.
Muto, A., Hori, M., Sasaki, Y., Saitoh, A., Yasuda, I., & Maekawa, T. (2007). Molecular Cancer Therapy, 6(3), 987–994.
Lee, H. Z. (2001). British Journal of Pharmacology, 134(1), 11–20.
Barnad, D. L., Huffman, J. H., Morris, J. L., Wood, S. G., Hughes, B. G., & Sidwell, R. W. (1992). Antiviral Research, 17(1), 63–67.
Mosmann, T. (1983). Journal Immunology Methodology, 65, 55–63.
Alessandro, F., Marco, S., Emanuela, M., Iacopo, S., Milena, P., & Oreste, G. (2002). Cancer, 95(9), 1902–1910.
Pucci-Minafra, I., Salvatore, M., Giampiero, L. R., Marillisa, B., Simona, F., Giuseppina, A., et al. (2001). Matrix Biology, 20(7), 419–427.
Bing, J. R., Masaru, M., Kathryn, A. R., Nicholas, H., Xuedong, W., Hentry, D. S., et al. (2001). Clinical Cancer Research, 7, 3385–3392.
Zucker, S., & Vacirca, J. (2004). Cancer Metastasis Reviews, 23(3), 101–117.
Tanaka, T., Metori, K., Mineo, S., Matsumoto, H., & Satoh, T. (1990). Yakugaku Zasshi, 110(9), 688–692.
Acknowledgement
The authors thank the Management of Karpagam University and G Srinivas Scientist C, Department of Biochemistry of Sree Chitra Tirunal Institute for Medical Sciences and Technology for providing lab facilities and constant encouragement for this research work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Damodharan, U., Ganesan, R. & Radhakrishnan, U.C. Expression of MMP2 and MMP9 (Gelatinases A and B) in Human Colon Cancer Cells. Appl Biochem Biotechnol 165, 1245–1252 (2011). https://doi.org/10.1007/s12010-011-9342-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-011-9342-8